• File Size 1.60 MB
• File Count 1
• Create Date January 28, 2025
• Last Updated January 28, 2025

Sino Biopharmaceuticals Valuation: A Deep Dive

Sino Biopharmaceutical Limited is a leading research-driven pharmaceutical conglomerate headquartered in China, focusing on the manufacturing and distribution of innovative drugs, generic drugs, and traditional Chinese medicine (TCM) products. With a diversified portfolio that spans multiple therapeutic areas, including oncology, cardiovascular diseases, respiratory health, and orthopedics, Sino Biopharmaceutical has emerged as a key player in China’s rapidly growing healthcare sector.